Strattera has a new bolded warning about severe liver injury

February 2005

Strattera has a new bolded warning about severe liver injury.

This is because of two new reports of extremely elevated liver enzymes...in a teen and an adult taking Strattera (atomoxetine) for attention deficit hyperactivity disorder (ADHD).

The enzymes increased several months into treatment...and normalized after stopping Strattera.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote